ALEC · Alector, Inc.
Trades by corporate insiders — officers, directors and holders of more than 10% of the shares — disclosed to the SEC on Forms 3, 4 and 5. Form 4 must be filed within two business days of the trade.
Insider Sentiment Score
Peer-relative 0–100 rank of how aggressively insiders accumulated over the trailing 90 days. See the full ranking.
| Date | Insider | Role | Type | Security | Shares |
|---|---|---|---|---|---|
| 2026-07-09 | Wong-Sarad Grace |
Principal Accounting Officer |
Award↑
Filing footnotes — Common Stock (Direct)
The reported shares are represented by restricted stock units, or RSUs, which vest in 12 equal quarterly installments beginning on September 1, 2026. |
Common Stock
|
20,000 |
| 2026-06-17 | Hammond Paula |
Director |
Award↑
Filing footnotes — Stock Option (right to buy) (Direct)
The shares subject to the option vest in 12 equal monthly installments beginning on July 17, 2026, provided that the shares subject to the option will vest in full on the earlier of the one-year anniversary of the date of grant or the date of the Issuer's next annual meeting of stockholders. |
Stock Option (right to buy)
|
9,450 |
| 2026-06-17 | SCHELLER RICHARD H |
Director |
Award↑
Filing footnotes — Stock Option (right to buy) (Direct)
The shares subject to the option vest in 12 equal monthly installments beginning on July 17, 2026, provided that the shares subject to the option will vest in full on the earlier of the one-year anniversary of the date of grant or the date of the Issuer's next annual meeting of stockholders. |
Stock Option (right to buy)
|
9,450 |
| 2026-06-17 | GAROFALO ELIZABETH A. |
Director |
Award↑
Filing footnotes — Common Stock (Direct)
The reported shares are represented by restricted stock units, or RSUs, which vest on the earlier of (i) June 17, 2027 or (ii) the date of the Issuer's next annual meeting of stockholders. |
Common Stock
|
28,700 |
| 2026-06-17 | Yaffe Kristine |
Director |
Award↑
Filing footnotes — Stock Option (right to buy) (Direct)
The shares subject to the option vest in 12 equal monthly installments beginning on July 17, 2026, provided that the shares subject to the option will vest in full on the earlier of the one-year anniversary of the date of grant or the date of the Issuer's next annual meeting of stockholders. |
Stock Option (right to buy)
|
9,450 |
| 2026-06-17 | Hammond Paula |
Director |
Award↑
Filing footnotes — Common Stock (Direct)
The reported shares are represented by restricted stock units, or RSUs, which vest on the earlier of (i) June 17, 2027 or (ii) the date of the Issuer's next annual meeting of stockholders. |
Common Stock
|
28,700 |
| 2026-06-17 | LAVIGNE LOUIS J JR |
Director |
Award↑
Filing footnotes — Common Stock (Direct)
The reported shares are represented by restricted stock units, or RSUs, which vest on the earlier of (i) June 17, 2027 or (ii) the date of the Issuer's next annual meeting of stockholders. |
Common Stock
|
28,700 |
| 2026-06-17 | DESOUZA ERROL B |
Director |
Award↑
Filing footnotes — Common Stock (Direct)
The reported shares are represented by restricted stock units, or RSUs, which vest on the earlier of (i) June 16, 2027 or (ii) the date of the Issuer's next annual meeting of stockholders. |
Common Stock
|
28,700 |
| 2026-06-17 | Yaffe Kristine |
Director |
Award↑
Filing footnotes — Common Stock (Direct)
The reported shares are represented by restricted stock units, or RSUs, which vest on the earlier of (i) June 17, 2027 or (ii) the date of the Issuer's next annual meeting of stockholders. |
Common Stock
|
28,700 |
| 2026-06-17 | GAROFALO ELIZABETH A. |
Director |
Award↑
Filing footnotes — Stock Option (right to buy) (Direct)
The shares subject to the option vest in 12 equal monthly installments beginning on July 17, 2026, provided that the shares subject to the option will vest in full on the earlier of the one-year anniversary of the date of grant or the date of the Issuer's next annual meeting of stockholders. |
Stock Option (right to buy)
|
9,450 |
| 2026-06-17 | Altmeyer Mark |
Director |
Award↑
Filing footnotes — Stock Option (right to buy) (Direct)
The shares subject to the option vest in 12 equal monthly installments beginning on July 17, 2026, provided that the shares subject to the option will vest in full on the earlier of the one-year anniversary of the date of grant or the date of the Issuer's next annual meeting of stockholders. |
Stock Option (right to buy)
|
9,450 |
| 2026-06-17 | SCHELLER RICHARD H |
Director |
Award↑
Filing footnotes — Common Stock (Direct)
The reported shares are represented by restricted stock units, or RSUs, which vest on the earlier of (i) June 17, 2027 or (ii) the date of the Issuer's next annual meeting of stockholders. |
Common Stock
|
28,700 |
| 2026-06-17 | DESOUZA ERROL B |
Director |
Award↑
Filing footnotes — Stock Option (right to buy) (Direct)
The shares subject to the option vest in 12 equal monthly installments beginning on July 17, 2026, provided that the shares subject to the option will vest in full on the earlier of the one-year anniversary of the date of grant or the date of the Issuer's next annual meeting of stockholders. |
Stock Option (right to buy)
|
9,450 |
| 2026-06-17 | Altmeyer Mark |
Director |
Award↑
Filing footnotes — Common Stock (Direct)
The reported shares are represented by restricted stock units, or RSUs, which vest on the earlier of (i) June 17, 2027 or (ii) the date of the Issuer's next annual meeting of stockholders. |
Common Stock
|
28,700 |
| 2026-06-17 | LAVIGNE LOUIS J JR |
Director |
Award↑
Filing footnotes — Stock Option (right to buy) (Direct)
The shares subject to the option vest in 12 equal monthly installments beginning on July 17, 2026, provided that the shares subject to the option will vest in full on the earlier of the one-year anniversary of the date of grant or the date of the Issuer's next annual meeting of stockholders. |
Stock Option (right to buy)
|
9,450 |
| 2026-06-03 | Wong-Sarad Grace |
Principal Accounting Officer |
Sell↓
Filing footnotes — Common Stock (Direct)
The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 Trading Plan adopted by the reporting person on September 5, 2025. The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $1.86 to $1.94. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff, the issuer, or any security holder of the issuer upon request. |
Common Stock
|
3,475 |
| 2026-06-02 | Berkley Neil Lindsay |
CFO & Chief Business Officer |
Sell↓
Filing footnotes — Common Stock (Direct)
The reported shares were sold to satisfy the reporting person's tax obligations in connection with the vesting of restricted stock units, or RSUs. The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $1.92 to $2.08. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff, the issuer, or any security holder of the issuer upon request. |
Common Stock
|
19,360 |
| 2026-06-02 | Wong-Sarad Grace |
Principal Accounting Officer |
Sell↓
Filing footnotes — Common Stock (Direct)
The reported shares were sold to satisfy the reporting person's tax obligations in connection with the vesting of restricted stock units, or RSUs. The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $1.92 to $2.08. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff, the issuer, or any security holder of the issuer upon request. |
Common Stock
|
5,709 |
| 2026-06-02 | Rosenthal Arnon |
Director, Chief Executive Officer |
Sell↓
Filing footnotes — Common Stock (Direct)
The reported shares were sold to satisfy the reporting person's tax obligations in connection with the vesting of restricted stock units, or RSUs. The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $1.92 to $2.08. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff, the issuer, or any security holder of the issuer upon request. |
Common Stock
|
87,216 |
| 2026-06-01 | SCHELLER RICHARD H |
Director |
Award↑
Filing footnotes — Common Stock (Direct)
The reported shares are represented by restricted stock units, or RSUs, which vest in 4 equal quarterly installments beginning on June 1, 2026. |
Common Stock
|
10,833 |
| 2026-04-16 | Wong-Sarad Grace |
Principal Accounting Officer |
Sell↓
Filing footnotes — Common Stock (Direct)
The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 Trading Plan adopted by the reporting person on September 5, 2025. |
Common Stock
|
1,820 |
| 2026-03-15 | Berkley Neil Lindsay |
CFO & Chief Business Officer |
Award↑
Filing footnotes — Common Stock (Direct)
The reported shares are represented by restricted stock units, or RSUs, one half (1/2) of the total shares shall vest on September 1, 2026 and one half (1/2th) of the total shares shall vest on March 1, 2027. |
Common Stock
|
54,600 |
| 2026-03-13 | Rosenthal Arnon |
Director, Chief Executive Officer |
Award↑
Filing footnotes — Common Stock (Direct)
The reported shares are represented by restricted stock units, or RSUs, one half (1/2) of the total shares shall vest on September 1, 2026 and one half (1/2th) of the total shares shall vest on March 1, 2027. |
Common Stock
|
116,246 |
| 2026-03-10 | Wong-Sarad Grace |
Principal Accounting Officer |
Sell↓
Filing footnotes — Common Stock (Direct)
The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 Trading Plan adopted by the reporting person on September 5, 2025. |
Common Stock
|
1,000 |
| 2026-03-03 | Wong-Sarad Grace |
Principal Accounting Officer |
Sell↓
Filing footnotes — Common Stock (Direct)
The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 Trading Plan adopted by the reporting person on September 5, 2025. The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $2.06 to $2.12. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff, the issuer, or any security holder of the issuer upon request. |
Common Stock
|
3,367 |
| 2026-03-02 | Wong-Sarad Grace |
Principal Accounting Officer |
Sell↓
Filing footnotes — Common Stock (Direct)
The reported shares were sold to satisfy the reporting person's tax obligations in connection with the vesting of restricted stock units, or RSUs. The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $2.04 to $2.37. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff, the issuer, or any security holder of the issuer upon request. |
Common Stock
|
8,071 |
| 2026-03-02 | Rosenthal Arnon |
Director, Chief Executive Officer |
Sell↓
Filing footnotes — Common Stock (Direct)
The reported shares were sold to satisfy the reporting person's tax obligations in connection with the vesting of restricted stock units, or RSUs. The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $2.04 to $2.37. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff, the issuer, or any security holder of the issuer upon request. |
Common Stock
|
81,864 |
| 2026-03-02 | Berkley Neil Lindsay |
CFO & Chief Business Officer |
Sell↓
Filing footnotes — Common Stock (Direct)
The reported shares were sold to satisfy the reporting person's tax obligations in connection with the vesting of restricted stock units, or RSUs. The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $2.04 to $2.37. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff, the issuer, or any security holder of the issuer upon request. |
Common Stock
|
29,649 |
| 2026-02-26 | Wong-Sarad Grace |
Principal Accounting Officer |
Sell↓
Filing footnotes — Common Stock (Direct)
The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 Trading Plan adopted by the reporting person on September 5, 2025. |
Common Stock
|
4,079 |
| 2025-12-05 | Wong-Sarad Grace |
Principal Accounting Officer |
Sell↓
Filing footnotes — Common Stock (Direct)
The sale reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on September 5, 2025. |
Common Stock
|
4,753 |
| 2025-12-03 | Rosenthal Arnon |
Director, Chief Executive Officer |
Sell↓
Filing footnotes — Common Stock (Direct)
The reported shares were sold to satisfy the reporting person's tax obligations in connection with the vesting of restricted stock units, or RSUs. The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $1.095 to $1.14. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff, the issuer, or any security holder of the issuer upon request. |
Common Stock
|
104,347 |
| 2025-12-03 | Wong-Sarad Grace |
Principal Accounting Officer |
Sell↓
Filing footnotes — Common Stock (Direct)
The reported shares were sold to satisfy the reporting person's tax obligations in connection with the vesting of restricted stock units, or RSUs. The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $1.095 to $1.14. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff, the issuer, or any security holder of the issuer upon request. |
Common Stock
|
8,056 |
| 2025-12-03 | Kenkare-Mitra Sara |
Director |
Sell↓
Filing footnotes — Common Stock (Direct)
The reported shares were sold to satisfy the reporting person's tax obligations in connection with the vesting of restricted stock units, or RSUs. The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $1.095 to $1.14. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff, the issuer, or any security holder of the issuer upon request. |
Common Stock
|
41,687 |
| 2025-12-03 | Berkley Neil Lindsay |
CFO & Chief Business Officer |
Sell↓
Filing footnotes — Common Stock (Direct)
The reported shares were sold to satisfy the reporting person's tax obligations in connection with the vesting of restricted stock units, or RSUs. The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $1.095 to $1.14. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff, the issuer, or any security holder of the issuer upon request. |
Common Stock
|
37,261 |
| 2025-11-10 | Wong-Sarad Grace |
Principal Accounting Officer |
Award↑
Filing footnotes — Common Stock (Direct)
The reported shares are represented by restricted stock units, or RSUs, which vest in 12 equal quarterly installments beginning on December 1, 2025. |
Common Stock
|
32,343 |
| 2025-11-10 | Berkley Neil Lindsay |
CFO & Chief Business Officer |
Award↑
Filing footnotes — Employee Stock Option (right to buy) (Direct)
Shares subject to the option vest in 48 equal monthly installments beginning on December 10, 2025. |
Employee Stock Option (right to buy)
|
195,000 |
| 2025-11-10 | Wong-Sarad Grace |
Principal Accounting Officer |
Award↑
Filing footnotes — Employee Stock Option (right to buy) (Direct)
Shares subject to the option vest in 48 equal monthly installments beginning on December 10, 2025. |
Employee Stock Option (right to buy)
|
48,535 |
| 2025-11-10 | Rosenthal Arnon |
Director, Chief Executive Officer |
Award↑
Filing footnotes — Common Stock (Direct)
The reported shares are represented by restricted stock units, or RSUs, which vest in 12 equal quarterly installments beginning on December 1, 2025. |
Common Stock
|
174,167 |
| 2025-11-10 | Rosenthal Arnon |
Director, Chief Executive Officer |
Award↑
Filing footnotes — Employee Stock Option (right to buy) (Direct)
Shares subject to the option vest in 48 equal monthly installments beginning on December 10, 2025. |
Employee Stock Option (right to buy)
|
522,500 |
| 2025-11-10 | Berkley Neil Lindsay |
CFO & Chief Business Officer |
Award↑
Filing footnotes — Common Stock (Direct)
The reported shares are represented by restricted stock units, or RSUs, which vest in 12 equal quarterly installments beginning on December 1, 2025. |
Common Stock
|
65,000 |
| 2025-09-02 | Kenkare-Mitra Sara |
Director |
Sell↓
Filing footnotes — Common Stock (Direct)
The reported shares were sold to satisfy the reporting person's tax obligations in connection with the vesting of restricted stock units, or RSUs. The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $2.30 to $2.59. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff, the issuer, or any security holder of the issuer upon request. |
Common Stock
|
23,638 |
| 2025-09-02 | Berkley Neil Lindsay |
CFO & Chief Business Officer |
Sell↓
Filing footnotes — Common Stock (Direct)
The reported shares were sold to satisfy the reporting person's tax obligations in connection with the vesting of restricted stock units, or RSUs. The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $2.30 to $2.59. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff, the issuer, or any security holder of the issuer upon request. |
Common Stock
|
15,842 |
| 2025-09-02 | Rosenthal Arnon |
Director, Chief Executive Officer |
Sell↓
Filing footnotes — Common Stock (Direct)
The reported shares were sold to satisfy the reporting person's tax obligations in connection with the vesting of restricted stock units, or RSUs. The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $2.30 to $2.59. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff, the issuer, or any security holder of the issuer upon request. The reported amount excludes 150,000 shares previously reported as performance share units, or PSUs. Because the performance metrics were not attained during the PSU measurement period, these PSUs were forfeited on May 6, 2025. |
Common Stock
|
51,562 |
| 2025-09-02 | Wong-Sarad Grace |
Principal Accounting Officer |
Sell↓
Filing footnotes — Common Stock (Direct)
The reported shares were sold to satisfy the reporting person's tax obligations in connection with the vesting of restricted stock units, or RSUs. The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $2.30 to $2.59. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff, the issuer, or any security holder of the issuer upon request. |
Common Stock
|
5,910 |
| 2025-08-26 | Hammond Paula |
Director |
Sell↓
Filing footnotes — Common Stock (Direct)
The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 Trading Plan adopted by the reporting person on May 27, 2025. The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $2.31 to $2.385. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff, the issuer, or any security holder of the issuer upon request. |
Common Stock
|
14,000 |
| 2025-07-01 | Kenkare-Mitra Sara |
Director |
Award↑
Filing footnotes — Employee Stock Option (right to buy) (Direct)
One third (1/3rd) of the total shares subject to the option shall vest on November 1, 2025, and one twelfth (1/12th) of the total shares subject to the option shall vest in equal monthly installments thereafter, provided that the shares subject to the option will vest in full on July 1, 2026. |
Employee Stock Option (right to buy)
|
18,250 |
| 2025-07-01 | Berkley Neil Lindsay |
CFO & Chief Business Officer |
Award↑
Filing footnotes — Employee Stock Option (right to buy) (Direct)
One third (1/3rd) of the total shares subject to the option shall vest on November 1, 2025, and one twelfth (1/12th) of the total shares subject to the option shall vest in equal monthly installments thereafter, provided that the shares subject to the option will vest in full on July 1, 2026. |
Employee Stock Option (right to buy)
|
18,000 |
| 2025-07-01 | Rosenthal Arnon |
Director, Chief Executive Officer |
Award↑
Filing footnotes — Common Stock (Direct)
The reported shares are represented by restricted stock units, or RSUs, one half (1/2) of the total shares shall vest on December 1, 2025 and one fourth (1/4th) of the total shares shall vest quarterly thereafter. |
Common Stock
|
137,125 |
| 2025-07-01 | Rosenthal Arnon |
Director, Chief Executive Officer |
Award↑
Filing footnotes — Employee Stock Option (right to buy) (Direct)
One third (1/3rd) of the total shares subject to the option shall vest on November 1, 2025, and one twelfth (1/12th) of the total shares subject to the option shall vest in equal monthly installments thereafter, provided that the shares subject to the option will vest in full on July 1, 2026. |
Employee Stock Option (right to buy)
|
45,700 |
| 2025-07-01 | Kenkare-Mitra Sara |
Director |
Award↑
Filing footnotes — Common Stock (Direct)
The reported shares are represented by restricted stock units, or RSUs, one half (1/2) of the total shares shall vest on December 1, 2025 and one fourth (1/4th) of the total shares shall vest quarterly thereafter. |
Common Stock
|
54,725 |